In Phase I, the ACCISS Study commissioned a first-of-its-kind report on the Insulin Market.
Since then, additional reports have covered other aspects of the market including patents, trade and the role of biosimilar insulin manufacturers. In 2021, a similar market report was published on self glucose monitoring market. Further research will be available as completed.
INSULIN MARKET PROFILE (2016) | Fact Sheet | Report
This profile identifies insulin manufacturers and countries where their products are registered and/or sold, the inclusion of insulin in national essential medicines lists, insulin product registration data, recent studies on the efficacy and safety of analogue and human insulin, and an estimate of the rate of insulin consumption for people with type 2 diabetes.
MARKET REPORT: DIABETES SELF-MONITORING DEVICES IN LMICS (2021) | Report| Factsheet
Self-monitoring of blood glucose is an essential aspect to diabetes care for people with type 1 diabetes, and for many with type 2 diabetes, particularly those who use insulin. To better understand the barriers to access to monitoring devices, the ACCISS Study, together with FIND, the global alliance for diagnostics, commissioned a report by the Clinton Health Access Initiative (CHAI) that outlined the current issues with access to self-monitoring devices.
INSULIN PRODUCTS AND DISTRIBUTORS | List
List of know insulin providers and distributors, compiled by ACCISS (updated annually)
THE ROLE OF BIOSIMILAR MANUFACTURERS IN IMPROVING ACCESS TO INSULIN GLOBALLY (2017) | Article
The production and use of generic medicines has substantially improved access to medicines in low-income and middle-income countries. The authors visited six biosimilar insulin manufacturers to better understand the challenges and opportunities that they face in supplying insulin globally.
INSULIN PATENT PROFILE (2016) | Fact Sheet | Report | Article
This profile uses data from various sources, including the United States Food and Drug Administration’s Orange Book and Health Canada, to determine the patent status of analogue and human insulins, and whether patents are a barrier to accessing insulin
INSULIN TRADE PROFILE (2016)| Fact Sheet | Report | Annexes: 3 | 4 | 5 | 6 | 7 | 8
From available trade databases and published literature, this profile maps the global trade of retail insulin and bulk insulin to show importing and exporting countries and their importance in global insulin trade. Countries that import insulin from only one country, making them vulnerable to possible disruptions in supply, are also identified.